As the title implies, this final rule clarifies and amends the discount safe harbor at 42 C.F.R. § 1001.925(h) under the federal Anti-kickback statute (AKS) such that rebates paid from drug manufacturers to Medicare Part D prescription drug plan sponsors or their pharmacy benefit managers (PBMs) are not protected from liability under the discount safe harbor. The rule also adds a new safe harbor for point-of-sale reductions in price that are passed on directly to a buyer (a defined term under the rule) and an additional safe harbor for “legitimate” service fees paid to PBMs by drug manufacturers.
OIG Finalizes Rebate Rules: Removal of Safe Harbor Protections for Rebates and Creation of New Safe Harbors for Other Discounts and Service Fees
More Issues
Wade’s Health Law Highlights for October 20, 2026
The Eleventh Circuit held in United States v. Chun that the government need only prove a defendant knowingly agreed to accept remuneration for referring…
Wade’s Health Law Highlights for October 13, 2026
A federal grand jury indicted Houston physician Dr. Joseph A. Montes on charges that he and others billed a federal COVID-19 program about $30…
Wade’s Health Law Highlights for October 6, 2026
A federal jury in Fort Worth convicted a Texas licensed professional counselor for a $26 million TRICARE fraud, kickback, and money laundering scheme. Kevin…
